EATG » Comorbidities

Comorbidities

HIV i-Base: HTB, special CROI issue

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. As CROI is a conference that keeps on giving, this issue of HTB continues with further reports from…

Patients with HIV face increased risk of mortality from lung cancer

The increased risk of cancer in patients with HIV has been well defined, and some studies have suggested that patients with HIV have not only a higher risk of lung…

Increased risk of peripheral artery disease with HIV infection

HIV infection is associated with a significantly increased risk of peripheral artery disease (PAD), according to results from the Veterans Aging Cohort Study (VACS). "HIV increases the risk of PAD…

HIV-associated cancers: a paradigm shift?

An increasing number of patients with HIV now live long enough to get the “incidental” cancers seen in the general population. Yet these patients are also less likely to get…

HIV-infected people are living for years, but age-related diseases set in early

David Hardy has been treating HIV-infected patients since the early 1980s, when the epidemic began. In those days, people newly diagnosed with AIDS lived for only about six months. Hardy,…

Relationship between CD4 counts, hypertension in patients with HIV

With the more recent availability of highly active antiretroviral therapy (HAART), patients living with HIV/AIDS are living longer, healthier lives. This increase in life expectancy is also associated with an…

CROI 2018: Researchers puzzle over whether HIV accelerates cancer progression

Although people living with HIV may be diagnosed with cancer at an earlier stage because they get more consistent care than the general population, it is also possible that a…

ILC 2018: EASL updates liver cancer guidelines

The European Association for the Study of the Liver (EASL) presented updated clinical practice guidelines for the management of hepatocellular carcinoma (HCC) during a special session at the 2018 International…

Eplerenone may improve inflammatory markers, but not insulin sensitivity in HIV

Insulin sensitivity and HbA1c were not substantially affected by treatment with eplerenone compared with placebo in adults with HIV; however, those assigned eplerenone saw improvements in HDL cholesterol, interleukin-6 and…

First-line ART failure common among hospitalised HIV-positive people in sub-Saharan Africa

A large proportion of hospitalised HIV-positive people in sub-Saharan Africa have experienced the failure of first-line antiretroviral therapy (ART), according to a study published in the journal Clinical Infectious Diseases.…

1 2 3 35